Status:
COMPLETED
A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Total Hip Replacement: The E-TRANS Fentanyl Transdermal System Versus the Morphine Intravenous Pump
Lead Sponsor:
Alza Corporation, DE, USA
Collaborating Sponsors:
PriCara, Unit of Ortho-McNeil, Inc.
Conditions:
Pain, Postoperative
Analgesia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare two pain medications delivered by two different forms of patient-controlled analgesia (PCA) management systems: the Fentanyl HCl Patient-Controlled Transdermal ...
Detailed Description
The purpose of this study is to compare two pain medications delivered by two different forms of patient-controlled analgesia (PCA). PCA is a form of pain management that allows the patient to control...
Eligibility Criteria
Inclusion
- Patients with a pre-operative American Society of Anesthesiology Physical Status I, II, or III (Class I are healthy persons less than 80 years of age, Class II are patients over age 80 years of age with mild systemic disease, and Class III are patients with severe and non-incapacitating disease)
- Admitted to the Post-Anesthesia Care Unit after general or spinal anesthesia (using bupivacaine)
- Surgical time of up to 4 hours for total hip replacement surgery with a single surgical incision
- Awake and breathing spontaneously, with a respiratory rate of 8 to 24 breaths per minute and oxygen saturation of 90% or higher (with or without supplemental oxygen)
- Expected to remain hospitalized for at least 24 hours postoperatively
Exclusion
- Patients whose post-operative pain would normally be managed with oral or non-narcotic pain medication
- Who received intraoperative spinal anesthesia other than bupivacaine (without epinephrine), intraoperative epidural anesthesia, or who are expected to have postoperative analgesia supplied by a continuous regional technique
- Have a history of allergy, hypersensitivity, or tolerance to fentanyl or morphine, or a history of allergy or hypersensitivity to cetylpyridinium chloride or skin adhesives, or have the presence of active skin disease that would interfere with application of the E-TRANS fentanyl system
- Who received systemic or intra-articular steroids within 1 month before surgery or during surgery
- Expected to require intensive care postoperatively or who will probably need additional surgical procedures within 72 hours
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
799 Patients enrolled
Trial Details
Trial ID
NCT00264485
Start Date
March 1 2004
End Date
April 1 2005
Last Update
May 19 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.